BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 15, 2014
View Archived Issues
Merck Research Laboratories describes discovery of potent HCV NS5B polymerase inhibitor prodrug
Read More
Domestic pesticide shows efficacy and safety for the treatment of INS
Read More
Early clinical and preclinical data presented for DS-5565
Read More
Shionogi presents highlights of fiscal 2013
Read More
Allecra Therapeutics reports on new potent beta-lactamase inhibitor
Read More
Chinese investigators test novel CLK1 inhibitors as anti-influenza agents
Read More
NOX4, a novel biomarker for non-valvular atrial fibrillation
Read More
Catabasis Pharmaceuticals presents preclinical data for CAT-2003
Read More
Aquilus Pharmaceuticals patents new MMP-13 inhibitors
Read More
Almirall divulges novel PI3Kdelta inhibitors
Read More
Calibr receives Gates Foundation research funding
Read More
Merck & Co. divulges new agents for HCV infection
Read More
Servier and Novartis enter into agreement for new drugs targeting apoptosis in oncology
Read More
Icahn School of Medicine awarded grant to investigate new therapy for eczema
Read More
Revive Therapeutics reports preclinical data for REV-003
Read More
BMS and Celldex Therapeutics to evaluate the combination of nivolumab and varlilumab
Read More
Daewoong Pharmaceutical synthesizes novel Na(V)1.7 blockers
Read More
Ono Pharmaceutical recaps progress of fourth quarter of fiscal 2013
Read More
Questcor licenses melanocortin peptides
Read More
Alexion studies ALXN-1007 for non-criteria manifestations of antiphospholipid syndrome
Read More
FDA grants nivolumab breakthrough therapy designation for Hodgkin's lymphoma
Read More
Novartis plans phase I/II study of CGF-166
Read More
Helix BioPharma seeks Canadian clearance for study of L-DOS47
Read More
ValiSeek reports encouraging results for VAL-401 development
Read More
Eisai resubmits additional benefit dossier for Fycompa in Germany
Read More